Amundi Asset Management US’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | $9.75M | Buy |
|
|||||
|
2020
Q4 | $8.73M | Sell |
|
|||||
|
2020
Q3 | $11.5M | Buy |
|
|||||
|
2020
Q2 | $13.8M | Buy |
|
|||||
|
2020
Q1 | $9.49M | Buy |
|
|||||
|
2019
Q4 | $10.2M | Buy |
|
|||||
|
2019
Q3 | $6.04M | Sell |
|
|||||
|
2019
Q2 | $8.52M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $8.35M | Sell |
|
|||||
|
2018
Q2 | $6.81M | Buy |
|
|||||
|
2018
Q1 | $4.86M | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $1.46M | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $5.93M | Sell |
|
|||||
|
2016
Q3 | $7.96M | Sell |
|
|||||
|
2016
Q2 | $7.18M | Sell |
|
|||||
|
2016
Q1 | $7.63M | Buy |
|
|||||
|
2015
Q4 | $10.7M | Buy |
|
|||||
|
2015
Q3 | $4.64M | Sell |
|
|||||
|
2015
Q2 | $6.89M | Sell |
|
|||||
|
2015
Q1 | $7.7M | Sell |
|
|||||
|
2014
Q4 | $5.33M | Sell |
|
|||||
|
2014
Q3 | $7.9M | Sell |
|
|||||
|
2014
Q2 | $7.59M | Buy |
|
|||||
|
2014
Q1 | $7M | Sell |
|
|||||
|
2013
Q4 | $4.9M | Buy |
|
|||||
|
2013
Q3 | $5.37M | Buy |
|
|||||
|
2013
Q2 | $3.32M | Buy |
|